Healthcare shares are mixed this pre-market. Pfizer Inc. (
) reported Q2 earnings of $0.56 per share, versus the Capital IQ
consensus of $0.55. Revenues were $12.97 billion, versus the
analyst estimate of $13.11 billion.
PFE reaffirms its FY13 guidance of $2.10 - $2.20 EPS versus the
consensus of $2.16; revenues are anticipated to be $50.8 billion -
$52.8 billion. The Street view for revenues of $51.9 billion.
The company also announced plans to move forward to internally
separate its commercial operations into three business segments.
PFE is up 0.07% at $29.56.
And Aetna (
) reported Q2 earnings of $1.52 per share, ex one-time items,
versus the Capital IQ consensus of $1.40. Revenues were $11.5
billion, versus the analyst estimate of $11.99 billion.
The company now expects FY13 EPS of $5.80 - $5.90, versus the
Street view of $5.82. Shares are up 2.7% at $65.08, with a 52-week
range of $35.48 - $66.00.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.